Paracha N, Reyes A, Dieras V, Krop I, et al. Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic HER2-positive breast cancer: a systematic review and network meta-analys Breast Cancer Res Treat 2020 Feb 25. pii: 10.1007/s10549-020-05577.
PMID: 32100144